In chronic myeloid leukemia (CML), the RalA gene was reported as a direct target of miR-181a, and is associated with cell proliferation, G2-phase arrest and apoptosis [21]. The gene discussed is RALA; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.